Kirsch Arthur S

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -35% 8.2% 15.1%
Success rate 7% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 1261%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Kirsch Arthur S's trades of Evommune Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-08 2026-07-07
US Evommune Inc (EVMN)
B Purchase
62,535 +48.6%
278.21
US$1,869,261 		62,535 +48.6% 278.21 US$1,869,261
2026-06-03 2026-06-03
US Liquidia Corp (LQDA)
S Sale
80,257 +17.2%
132.61
US$4,414,023 		80,257 +17.2% 132.61 US$4,414,023
2026-06-03 2026-06-02
US Liquidia Corp (LQDA)
S Sale
96,692 +45.4%
242.08
US$2,638,091 		96,692 +45.4% 242.08 US$2,638,091
2026-06-03 2026-06-01
US Liquidia Corp (LQDA)
S Sale
15,000 -50.0%
60.22
US$903,300 		15,000 -50.0% 60.22 US$903,300
2026-06-01 2026-06-01
US Liquidia Corp (LQDA)
PrS Proposed sale
30,000
61.37
US$1,841,100 		30,000 61.37 US$1,841,100
2021-11-12 2021-11-10
US Liquidia Corp (LQDA)
B Purchase
30,000 +1500.0%
4.24
US$127,200 		30,000 +1500.0% 4.24 US$127,200